Home
NICE Guidance
Conditions and diseases
Diabetes and other endocrinal, nutritional and metabolic conditions
Diabetes
Dapagliflozin in combination therapy for treating type 2 diabetes
Technology appraisal guidance [TA288]
Published:
26 June 2013
Last updated:
23 November 2016
Guidance
Tools and resources
Information for the public
Evidence
History
Do no do examples
Do no do examples for Dapagliflozin in combination therapy for treating type 2 diabetes
Title
Year published
Impact Level
No results could be found